-
Geron Enters New Innovative Licensing and Access Pathway in the United Kingdom for Imetelstat
25 Oct 2021 22:43 GMT
… clinical trial achieved durable transfusion independence with imetelstat treatment, including … Passport, an experimental drug needs to meet … the following: innovative medicine, clinically significant new … Phase 3 clinical trials: IMerge in lower …
-
The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology
12 Oct 2021 12:47 GMT
… treatment)
Bicycle Therapeutics plc (NASDAQ: BCYC)
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA)
Itamar Medical … trial to closely matched real world data.
For the imetelstat … 39;s Stomach Cancer Drug Approved In Switzerland
Deciphera Pharmaceuticals, Inc. ( …
-
The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business
17 Aug 2021 13:00 GMT
… shot and FDA approval for its vaccine for tick … (NASDAQ: MDNA)
MediciNova, Inc. (NASDAQ: MNOV)
Moleculin Biotech, Inc. (NASDAQ … To Initiate Clinical Trial Of Lymphoma Treatment
Corvus Pharmaceuticals, Inc. (NASDAQ … Greater China Rights To Cancer Drug For Up To …
-
The Daily Biotech Pulse: Orphazyme Falters At FDA, Athira's CEO Placed On Temporary Leave, 5 IPOs
18 Jun 2021 12:08 GMT
… Medical Incorporated (NASDAQ: NTUS)
NovoCure Limited (NASDAQ: NVCR)
Portage Biotech … drug application, seeking approval for arimoclomol as a treatment … of imetelstat observed … cancer vaccine candidate BNT111 in combination with Regeneron, Pharmaceuticals …
-
Geron Stock Trading Is Higher On Reinforcing Imetelstat's Approach For Myelofibrosis Treatment, With Data Publication In Journal
18 Jun 2021 11:07 GMT
… the IMbark Phase 2 trial of imetelstat for myelofibrosis (MF) … disease-modifying activity of imetelstat.
"Targeting the … MF malignant clones differentiates imetelstat from other therapeutic agents … are refractory to prior treatment with a JAK inhibitor, …
-
Geron Reports Ten Imetelstat Presentations at American Society of Hematology Annual Meeting
08 Dec 2020 01:41 GMT
… D., Geron’s Chief Medical Officer. “We believe … telomere biology in cancer cells and provide … in the treatment phase continue to receive imetelstat treatment, per … AMERICA
INDUSTRY KEYWORD: BIOTECHNOLOGY PHARMACEUTICAL HEALTH CLINICAL TRIALS
SOURCE: Geron …
-
Geron Announces Fifty Percent Enrollment Milestone in IMerge Phase 3 Clinical Trial in Lower Risk MDS
10 Dec 2020 14:43 GMT
… D., Geron’s Chief Medical Officer. “We believe … that imetelstat could become a much-needed treatment alternative … clinical trial with registration intent. The trial is …
INDUSTRY KEYWORD: BIOTECHNOLOGY PHARMACEUTICAL HEALTH CLINICAL TRIALS
SOURCE: Geron …
-
Polycythemia Vera Pipeline Report presents an Updated Clinical Data of all the companies working in the Polycythemia Vera drug development scenario.
09 Dec 2020 13:19 GMT
… Pharmaceuticals AG/ PharmaEssentia are Marketed Products in Polycythemia Vera Drugs … the Polycythemia Vera treatment. Drugs under development … phase II clinical trials in patients.
Bomedemstat … Promedior/Roche
Imetelstat (GRN163L): Geron Corporation …
-
Geron: Pandemic And Legal Trials Cloud A Promising Clinical Trial
09 Nov 2020 15:30 GMT
… stage candidate, imetelstat, towards Phase III trials targeting MDS … forms of blood cancers with a significant unmet medical need. With … rights for the drug after Janssen Biotech ended the co … subsequent discussions with FDA set the trial design for IMpactMF, …
-
The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trial Readouts
08 Jun 2019 20:35 GMT
… as a first-line treatment option for patients … disease), June 14.
Blueprint Medicines Corp (NASDAQ: BPMC): … (non-Hodgkin lymphoma).
Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS): … updated Phase 2 data for Imetelstat (Myelodysplastic syndromes), June 15 …
About
© 1995-2021